CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Orlando Health

Melissa Morgan, Assistant Vice President, Quality, Safety, and Regulatory

Improving Patient Safety and Care with Implementing New Programs

Melissa Morgan

Melissa Morgan

Brief Background on Your Roles in the Organizations


I began my healthcare career as a paramedic before becoming a nurse. I have worked in multiple healthcare environments before transitioning to infection prevention. As an infection prevention specialist and leader, I have had the opportunity to influence women’s health, intensive care, medical, trauma, surgery, and ambulatory spaces approach to infection prevention. As the pandemic began, I gained great insight into local, state, and federal collaboration in infection prevention, as well as learned the challenges of county and state lines. Having worked in several large healthcare organizations on the East and West Coast has allowed me to gain great insights that influence my role and responsibilities each day.


Significant Trends in the Field Patient Safety and Care


The basics of infection prevention continue to be challenging. I have always said it is the free things that would eliminate the need for my job, but they are often the most difficult to gain compliance and understanding for as you do not usually see the consequence. From an infection prevention perspective, it is critical to engage with staff. Although there is a significant focus on staff shortages in both nursing and providers across the country, I believe staffing turnover impacts patient safety and care even outside these specific clinicians. Departments such as environmental services, who are the foundational infection preventionists, are also struggling with staffing. The electronic health record has helped us connect patient care through multiple providers, but what has been more impactful is the development of technology or providing care outside the traditional hospital setting. Historically, infection prevention programs have been hospital-based despite the continued expansion of most health systems into ambulatory settings. As technology has advanced and care is pushed outside the hospital setting, complex procedures that require specific infection prevention guidelines inside the hospital are now being performed in practice without infection prevention partnership and patient safety.


Although there is significant focus on staff shortages in both nursing and providers across the country, I believe staffing turnover impacts patient safety and care even outside these specific clinicians.


Pressing Challenges in Overseeing Infection Prevention Programs


Infection prevention programs are influenced by the organization themselves as well as regulations. In my experience, healthcare systems lean toward ensuring resources for programs that drive improvement. Unfortunately, when the infection prevention program is not resourced adequately, the subject matter expertise can get lost as solutions tend to be focused on individual infection occurrence versus trend analysis or organism-specific indicators of practice gaps. Infection prevention is most valuable when they can be at the elbow of those doing the work. When managing an infection prevention program, understanding how the work is done has helped me develop strategies that involve products and technology. Resources do not always mean people are needed. For example, providing the infection preventionist with a mobile device can promote more rounding and interaction with direct patient care to influence immediate change and gain efficiency.


Innovative Technologies Implemented at Orlando Health


I think the innovation I am most excited about is the development of an app for the end user to access transmission-based precautions. Every organization I have worked for, as well as most colleagues I know, utilize the CDC Guideline for isolation precautions. This is a 206-page document that includes an appendix providing the type and duration of precautions. Most infection prevention programs use this guideline for policy and typically link or include the appendix. Unfortunately, I have found that clinicians struggle to access this information through a policy. This results in delayed precautions, exposures, and quite a bit of time involved in calls, messages, and follow-up. I built an app that allows for access on any mobile or desktop device that has Power apps by Microsoft Office suite available. It is super simple and only requires the user to know at least a few letters of what they are looking for, creating instant access for pertinent isolation precautions. With a culture of ‘we need an app for that,’ I built one.


Integrating New Best Practices in Disinfection and Sterilization Impacting Healthcare Facilities Operations and Protocols


Disinfection and sterilization are evolving at a rapid pace to improve patient safety, given the outbreaks that have made headlines over the last few years. This is where the influence and partnership with infection prevention can have the most value. Infection prevention can highlight for the organization that by spending the money to design a space that provides high water quality, appropriate environment, adequate space for cleaning and disinfection, and investing in innovative technologies, efficiencies can be realized that allow for more procedures resulting in increased revenues. This also reduces the cost of readmission and complications that are typically not a part of a new service line business plan but can be expensive to any organization as well as the impact on the patient.


Advice for Other Senior Leaders and CXOs Working in the Industry


My advice for senior leaders would be to understand what your infection prevention program is providing you by spending time with the department. Understand that they are more than just the hand hygiene police or the messengers of unwelcome news with an identification of healthcare-associated infection. Lean into understanding the experience and resources the program's leadership has, and provide them access to national resources to learn and grow as a leader so that they can help create the safest healthcare system possible.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/cxoinsight/improving-patient-safety-and-care-with-implementing-new-programs-nwid-2931.html